Your browser doesn't support javascript.
loading
Characteristics of opioid users undergoing surgery for pelvic organ prolapse.
Leach, Douglas Allan; Scarlotta, Leah S; Habermann, Elizabeth B; Glasgow, Amy E; Occhino, John A.
Afiliação
  • Leach DA; Division of Gynecologic Surgery, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA. Leach.Douglas@mayo.edu.
  • Scarlotta LS; Department of Obstetrics and Gynecology, Walter Reed National Military Medical Center, 8901 Wisconsin Avenue, Bethesda, MD, USA.
  • Habermann EB; Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN, USA.
  • Glasgow AE; Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN, USA.
  • Occhino JA; Division of Gynecologic Surgery, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.
Int Urogynecol J ; 31(9): 1891-1897, 2020 09.
Article em En | MEDLINE | ID: mdl-31989200
ABSTRACT
INTRODUCTION AND

HYPOTHESIS:

Understanding demographic and opioid utilization patterns of preoperative opioid users compared with opioid-naïve patients undergoing surgical treatment for pelvic organ prolapse (POP) better informs opioid prescribing.

METHODS:

A cohort of preoperative opioid users undergoing surgery for POP from 1 January 2012 through 30 May 2017 was identified. Electronic medical records were utilized to obtain pain scores and prescription data. The cohort was organized by surgical approach, number of concomitant procedures, and patient age. These factors were then matched to pain scores, opioid quantity prescribed at discharge, and subsequent refills. Pain scores and opioid use were evaluated for correlation. Results were then compared with similar data previously published for opioid-naïve patients undergoing surgical treatment of POP.

RESULTS:

Preoperative opioid users were younger (55.5 [14.7] vs 59.5 [12.7]; p = 0.002), of higher body mass index (BMI; 29.2 [5.4] vs 28.6 [10.3]; p = 0.04), and less likely Caucasian (90.3% vs 95.9%; p = 0.002) than opioid-naïve patients. After matching for these differences, opioid users reported higher pain scores (3.5 [2.2] vs 2.6 [1.8]; p = <0.0001), but received similar opioid quantities (324.4 [395] vs 296 [158] oral morphine equivalents [OME]; p = 0.27; 16.8% vs 10.4% refill rates; p = 0.07). In preoperative opioid users, neither surgical approach nor the number of concomitant procedures influenced pain scores. Increasing mean pain scores (1.8 [2.0] to 4.2 [2.4]; p < 0.002) and OME prescribed (226 [170.2] to 541 [902.5] p = 0.056; 0% to 22.2% refill rates; p = 0.02), were seen with decreasing patient age. Pain scores correlated directly with the opioid amount prescribed.

CONCLUSIONS:

Patient age and preoperative opioid utilization should be factored into urogynecological postoperative opioid-prescribing protocols.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Prolapso de Órgão Pélvico / Analgésicos Opioides Tipo de estudo: Etiology_studies / Guideline / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Prolapso de Órgão Pélvico / Analgésicos Opioides Tipo de estudo: Etiology_studies / Guideline / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article